Chondrosarcoma natural history

Chondrosarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Chondrosarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Chondrosarcoma natural history On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Chondrosarcoma natural history All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chondrosarcoma natural history
CDC on Chondrosarcoma natural history
Chondrosarcoma natural history in the news
Blogs on Chondrosarcoma natural history
Directions to Hospitals Treating Chondrosarcoma
Risk calculators and risk factors for Chondrosarcoma natural history

Overview

Complications that can develop as a result of chondrosarcoma are metastasis and recurrence. The prognosis of chondrosarcoma is good with treatment. Chondrosarcoma is associated with a 5 year survival rate of 75%. The presence of grade 3 lesions are associated with a particularly poor prognosis.

Complications

• Chondrosarcoma may cause metastasis to other organs.
• Lung is the most common location for metastatic disease.
• Chondrosarcoma may recur and may need treatment with surgery, chemotherapy or radiation. Unlike other cancers, chondrosarcoma can return many years later. Follow up scans are extremely important for chondrosarcoma to make sure there has been no recurrence or metastasis.

Prognosis

• Generally, chondrosarcoma carries a good prognosis.
• Chondrosarcoma is associated with a 5 year survival rate of 75%.
• Depending upon the subtype, prognosis vary substantially:
  • Chondrosarcoma NOS: 70% 5 year survival.
  • Myxoid chondrosarcoma: 70% 5 year survival.
  • Mesenchymal chondrosarcoma: 50% 5 year survival.
  • Dedifferentiated chondrosarcoma: 10% 5 year survival.
• Prognosis varies with grade:
  • Grade 1: 90% 5 year survival.
  • Grade 3: 29% 5 year survival
• Prognosis varies with location:
  • long bones have a better prognosis than axial skeleton.

References

Template:WikiDoc Sources